We are live on ! Find out more
E

Ergoteles Portfolio holdings

AUM $68.2M
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+7.33%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.36B
AUM Growth
+$1.15B
Cap. Flow
+$991M
Cap. Flow %
22.7%
Top 10 Hldgs %
14.65%
Holding
1,807
New
1,048
Increased
148
Reduced
170
Closed
353

Top Buys

Rank Stock Value
1
PRAH
PRA Health Sciences, Inc.
PRAH
+$160M
2
IBB icon
iShares Biotechnology ETF
IBB
+$77.5M
3
LIN icon
Linde
LIN
+$51M
4
XME icon
State Street SPDR S&P Metals & Mining ETF
XME
+$46M
5
NEM icon
Newmont
NEM
+$44.6M

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$66.5M
2
XOM icon
ExxonMobil
XOM
+$54.9M
3
AAPL icon
Apple
AAPL
+$52.1M
4
HMSY
HMS Holdings Corp.
HMSY
+$48.4M
5
ORCL icon
Oracle
ORCL
+$42.3M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Healthcare 14.66%
3 Consumer Discretionary 14.56%
4 Financials 10.08%
5 Industrials 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APG icon
1476
APi Group
APG
$17.1B
– –
-43,950
Closed -$606K
APPN icon
1477
Appian
APPN
$1.74B
– –
-57,750
Closed -$7.68M
ARCT icon
1478
Arcturus Therapeutics
ARCT
$157M
– –
-5,533
Closed -$229K
ARDX icon
1479
Ardelyx
ARDX
$1.24B
– –
-10,621
Closed -$70K
ARKO icon
1480
ARKO Corp
ARKO
$890M
– –
-13,932
Closed -$138K
ARLO icon
1481
Arlo Technologies
ARLO
$1.4B
– –
-34,000
Closed -$214K
AROC icon
1482
Archrock
AROC
$6.33B
– –
-36,000
Closed -$342K
ASND icon
1483
Ascendis Pharma A/S
ASND
$16.7B
– –
-18,547
Closed -$2.39M
ATEC icon
1484
Alphatec Holdings
ATEC
$1.27B
– –
-20,557
Closed -$325K
ATI icon
1485
ATI
ATI
$27B
– –
-18,261
Closed -$385K
AVIR icon
1486
Atea Pharmaceuticals
AVIR
$379M
– –
-50,362
Closed -$3.11M
BA icon
1487
Boeing
BA
$165B
– –
-2,000
Closed -$509K
BALY icon
1488
Bally's
BALY
$672M
– –
-21,618
Closed -$1.41M
BBAX icon
1489
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$6.56B
– –
-15,388
Closed -$874K
BBEU icon
1490
JPMorgan BetaBuilders Europe ETF
BBEU
$9.13B
– –
-10,567
Closed -$579K
BBWI icon
1491
Bath & Body Works
BBWI
$4.01B
– –
-324,349
Closed -$16.2M
BBY icon
1492
Best Buy
BBY
$18B
– –
-66,107
Closed -$7.59M
BEAM icon
1493
Beam Therapeutics
BEAM
$2.58B
– –
-116,855
Closed -$9.35M
BEKE icon
1494
KE Holdings
BEKE
$16.8B
– –
-139,403
Closed -$7.94M
BILI icon
1495
Bilibili
BILI
$7.18B
– –
-19,965
Closed -$2.14M
BIPC icon
1496
Brookfield Infrastructure
BIPC
$5.11B
– –
-4,952
Closed -$252K
BKU icon
1497
Bankunited
BKU
$3.38B
– –
-6,659
Closed -$293K
BLFS icon
1498
BioLife Solutions
BLFS
$1.46B
– –
-8,000
Closed -$288K
BLUE
1499
DELISTED
bluebird bio
BLUE
– –
-9,945
Closed -$3.88M
BMRC icon
1500
Bank of Marin Bancorp
BMRC
$466M
– –
-5,778
Closed -$226K
58 59
60
61 62

Similar funds

ROC
River Oaks Capital Wayzata, Minnesota $67.9M AUM 13.58% 1-Year Est. Return
IVMX
Institutional Venture Management XIV Menlo Park, California $67.7M AUM 8.12% 1-Year Est. Return
AM
Anqa Management Sag Harbor, New York $66.5M AUM 36.45% 1-Year Est. Return
JCG
John C. Goff $70.7M AUM 4.99% 1-Year Est. Return
JAMONY
Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return
FA
Financial Advantage Columbia, Maryland $65.2M AUM 14.55% 1-Year Est. Return
VCM
Vetamer Capital Management Menlo Park, California $72M AUM 31% 1-Year Est. Return
MCMI
Matrix China Management IV Grand Cayman, Cayman Islands $64.3M AUM 53.64% 1-Year Est. Return

Ergoteles's Q2 2021 Portfolio in Review

As of Q2 2021, Ergoteles held 1,807 positions worth $4.36B, up 36% from $3.21B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Ergoteles deployed $991M of net new capital in Q2 2021, opening 1,048 new positions and adding to 148 existing holdings. Its largest new stake was Linde: 174,841 shares worth $50.5M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Walt Disney, an estimated $66.5M trimmed.

  • Ergoteles's largest Q2 2021 buy was Linde: 174,841 shares worth $50.5M.
  • Ergoteles added most to PRA Health Sciences, Inc. in Q2 2021, an estimated $160M increase.
  • Ergoteles's biggest Q2 2021 reduction was Walt Disney, cutting an estimated $66.5M.
  • Ergoteles fully exited ExxonMobil in Q2 2021, selling an estimated $54.9M.
  • Ergoteles's ten largest holdings make up 15% of its $4.36B portfolio in Q2 2021.
  • Ergoteles opened 1,048 new positions and closed 353 in Q2 2021.
  • Ergoteles's portfolio value rose 36% quarter-over-quarter to $4.36B.

Based on Ergoteles's 13F filing for Q2 2021, filed 12 Aug 2021.